Nukleotidsekvenser som koder for antigener fra HIV-1-retrovirus gruppe (eller undergruppe) O, transmembrane kappepeptider og retoviruscapsidproteiner og -peptider

A protein (I) of HIV-1 (sub) group O (or natural or synthetic (poly)peptides contg. at least part of (I)) that can be recognised by antibodies isolated from the serum obtained after infection with the strains HIV-1 group O VAU or HIV-1 (sub) group O DUR is new.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MONTAGNIER, LUC, COHEN, JACQUES, H., M, CLAVEL, FRANCOIS, CHARNEAU, PIERRE, GUETARD, DENISE, BORMAN, ANDREW, QUILLENT, CAROLINE, DONJON DE SAINT-MARTIN, JACQUELINE
Format:	Patent
Sprache:	dan
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA DERIVATIVES THEREOF ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS SUGARS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A protein (I) of HIV-1 (sub) group O (or natural or synthetic (poly)peptides contg. at least part of (I)) that can be recognised by antibodies isolated from the serum obtained after infection with the strains HIV-1 group O VAU or HIV-1 (sub) group O DUR is new.